07:00 , Jun 17, 2013 |  BC Week In Review  |  Financial News

Ocular Therapeutix financial update

Ocular Therapeutix raised an undisclosed amount in an extension of its series D round. Baxter Ventures and Ascension Health Ventures participated in the financing. The company raised $23.8 million in an extension of the round...
08:00 , Feb 4, 2013 |  BC Week In Review  |  Financial News

Ocular Therapeutix financial update

Ocular Therapeutix raised $23.8 million in an extension of a series D round, bringing the total raised in the round to $37.8 million. All of the company's existing institutional investors participated, including Polaris Venture Partners;...
01:28 , Jan 29, 2013 |  BC Extra  |  Financial News

Ocular raises $23.8M in series D extension

Ocular Therapeutix Inc. (Bedford, Mass.) raised $23.8 million in an extension of a series D round, bringing the total raised in the round to $37.8 million. All of the company's existing institutional investors participated, including...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Financial News

PathoGenetiX financial update

PathoGenetiX raised $7.5 million in the second close of a series B round, bringing the total raised in the round to $11.5 million. New investor Ascension Health Ventures joined existing investors Excel Venture Management; CB...
08:00 , Feb 7, 2011 |  BC Week In Review  |  Financial News

Ocular Therapeutix completes venture financing

Ocular Therapeutix Inc. , Waltham, Mass.   Business: Ophthalmic   Date completed: 2/2/11   Type: Venture financing   Raised: $14 million   Investors: Ascension Health Ventures; Polaris Venture Partners; SV Life Sciences; Versant Ventures  ...
07:00 , Oct 26, 2009 |  BC Week In Review  |  Financial News

Augmenix completes venture financing

Augmenix Inc. , Waltham, Mass.   Business: Supply/Service   Date completed: 10/16/09   Type: Venture financing   Raised: $6.1 million   Investors: Ascension Health Ventures; Versant Ventures; Pinnacle Ventures; Catalyst Health Ventures; private investors  ...